BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 22702366)

  • 1. Epigenetic biomarkers in colorectal cancer diagnostics.
    Rawson JB; Bapat B
    Expert Rev Mol Diagn; 2012 Jun; 12(5):499-509. PubMed ID: 22702366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-translational histone modifications in circulating nucleosomes as new biomarkers in colorectal cancer.
    Gezer U; Holdenrieder S
    In Vivo; 2014; 28(3):287-92. PubMed ID: 24815828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic biomarkers of colorectal cancer: Focus on DNA methylation.
    Coppedè F
    Cancer Lett; 2014 Jan; 342(2):238-47. PubMed ID: 22202641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic biomarkers in laboratory diagnostics: emerging approaches and opportunities.
    Sandoval J; Peiró-Chova L; Pallardó FV; García-Giménez JL
    Expert Rev Mol Diagn; 2013 Jun; 13(5):457-71. PubMed ID: 23782253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and epigenetic biomarkers of colorectal cancer.
    Choong MK; Tsafnat G
    Clin Gastroenterol Hepatol; 2012 Jan; 10(1):9-15. PubMed ID: 21635968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic biomarkers in colorectal cancer: premises and prospects.
    Zamani M; Hosseini SV; Mokarram P
    Biomarkers; 2018 Mar; 23(2):105-114. PubMed ID: 27788596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic regulation and colorectal cancer.
    Matsubara N
    Dis Colon Rectum; 2012 Jan; 55(1):96-104. PubMed ID: 22156874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetics of colorectal cancer.
    Migheli F; Migliore L
    Clin Genet; 2012 Apr; 81(4):312-8. PubMed ID: 22263639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in epigenetic biomarker research in colorectal cancer.
    Wang X; Kuang YY; Hu XT
    World J Gastroenterol; 2014 Apr; 20(15):4276-87. PubMed ID: 24764665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal cancer epigenetics: complex simplicity.
    van Engeland M; Derks S; Smits KM; Meijer GA; Herman JG
    J Clin Oncol; 2011 Apr; 29(10):1382-91. PubMed ID: 21220596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Road to early detection of pancreatic cancer: Attempts to utilize epigenetic biomarkers.
    Fukushige S; Horii A
    Cancer Lett; 2014 Jan; 342(2):231-7. PubMed ID: 22450751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of molecular markers in the diagnosis of colorectal cancer screening.
    Schmid G
    Dig Dis; 2010; 28(4-5):625-8. PubMed ID: 21088414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of epigenetics in colorectal cancer.
    Coppedè F
    Expert Rev Gastroenterol Hepatol; 2014 Nov; 8(8):935-48. PubMed ID: 24871610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-dependent clinical prognostic value of histone modifications in colorectal cancer.
    Goossens-Beumer IJ; Benard A; van Hoesel AQ; Zeestraten EC; Putter H; Böhringer S; Liefers GJ; Morreau H; van de Velde CJ; Kuppen PJ
    Transl Res; 2015 May; 165(5):578-88. PubMed ID: 25488396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic biomarkers in prostate cancer: Current and future uses.
    Chiam K; Ricciardelli C; Bianco-Miotto T
    Cancer Lett; 2014 Jan; 342(2):248-56. PubMed ID: 22391123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolving molecular classification by genomic and proteomic biomarkers in colorectal cancer: potential implications for the surgical oncologist.
    Søreide K; Nedrebø BS; Knapp JC; Glomsaker TB; Søreide JA; Kørner H
    Surg Oncol; 2009 Mar; 18(1):31-50. PubMed ID: 18672360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA signatures: novel biomarker for colorectal cancer?
    Luo X; Burwinkel B; Tao S; Brenner H
    Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1272-86. PubMed ID: 21551242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of epigenetic events in chemical carcinogenesis--a justification for incorporating epigenetic evaluations in cancer risk assessment.
    Koturbash I; Beland FA; Pogribny IP
    Toxicol Mech Methods; 2011 May; 21(4):289-97. PubMed ID: 21495867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic alterations as cancer diagnostic, prognostic, and predictive biomarkers.
    Deng D; Liu Z; Du Y
    Adv Genet; 2010; 71():125-76. PubMed ID: 20933128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter CpG island methylation markers in colorectal cancer: the road ahead.
    Draht MX; Riedl RR; Niessen H; Carvalho B; Meijer GA; Herman JG; van Engeland M; Melotte V; Smits KM
    Epigenomics; 2012 Apr; 4(2):179-94. PubMed ID: 22449189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.